Senseonics (SENS) “announced a mutually executed Memorandum of Understanding to transition all commercialization and distribution of Eversense 365 and future products from Ascensia Diabetes Care, a member of PHC Group, to Senseonics. By unifying the Eversense business and incorporating commercial activities directly within Senseonics, the companies believe Eversense would achieve accelerated growth and realize its full potential faster than under the current structure.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SENS:
- Senseonics initiated with an Overweight at Barclays
- Senseonics (SENS) Earnings Call Highlights Growth and Future Plans
- Senseonics Holdings: Strong Financial Performance and Strategic Initiatives Drive Buy Rating
- Senseonics Holdings Reports Strong Q2 Revenue Growth
- Senseonics reports Q2 EPS (2c), consensus (2c)